Caixin
Jan 25, 2022 09:51 PM
CHINA

Hong Kong Researchers Develop Oral Covid-19 Treatment

The research team is in touch with pharmaceutical companies, in hopes of moving forward with clinical trials and the manufacturing of the drug combination. Photo: University of Hong Kong
The research team is in touch with pharmaceutical companies, in hopes of moving forward with clinical trials and the manufacturing of the drug combination. Photo: University of Hong Kong

Hong Kong researchers have discovered a new combination of drugs that could work as an orally administered Covid-19 treatment.

The broad-spectrum antiviral medication has the potential to facilitate treatment at home and reduce the burden at hospitals, they say

Researchers from the University of Hong Kong evaluated the combined use of clinically used drugs, colloidal bismuth subcitrate (CBS) and N-acetyl cysteine (NAC), and found that the cocktail therapy — a combination of two or more drugs — suppresses the replication cycle of the virus, reduces viral loads in the lung and ameliorates virus-induced pneumonia in a hamster infection model, according to the paper published in the journal of Chemical Science.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription